We are live on ! Find out more
AI

ArchPoint Investors Portfolio holdings

AUM $420M
1-Year Est. Return 42.19%
This Fund
S&P 500
This Quarter Est. Return
-0.66%
1 Year Est. Return
+42.19%
3 Year Est. Return
+98.24%
5 Year Est. Return
+100.5%
10 Year Est. Return
+371.01%
AUM
$337M
AUM Growth
+$3.25M
Cap. Flow
+$6.98M
Cap. Flow %
2.07%
Top 10 Hldgs %
64.52%
Holding
135
New
17
Increased
7
Reduced
22
Closed
68

Top Buys

Rank Stock Value
1
RXRX icon
Recursion Pharmaceuticals
RXRX
+$23.6M
2
S icon
SentinelOne
S
+$13.2M
3
HOOD icon
Robinhood
HOOD
+$12.5M
4
GRAB icon
Grab
GRAB
+$8.07M
5
NAUT icon
Nautilus Biotechnolgy
NAUT
+$7.76M

Sector Composition

Rank Sector Weight
1 Communication Services 29.28%
2 Healthcare 18.93%
3 Consumer Discretionary 17.86%
4 Technology 10.44%
5 Energy 6.8%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GOOGL icon
1
Alphabet (Google) Class A
GOOGL
$4.08T
$90.2M 26.76%
622,760
-185,680
-23% -$26.7M
AMZN icon
2
Amazon
AMZN
$2.48T
$27.8M 8.24%
166,540
-12,420
-7% -$2.13M
RXRX icon
3
Recursion Pharmaceuticals
RXRX
$1.62B
$21.5M 6.38%
+1,255,430
New +$23.6M
LZB icon
4
La-Z-Boy
LZB
$1.65B
$16.9M 5.03%
466,746
S icon
5
SentinelOne
S
$6.29B
$11.4M 3.37%
+224,890
New +$13.2M
DMLP icon
6
Dorchester Minerals
DMLP
$1.3B
$10.9M 3.23%
549,814
-4,616
-0.8% -$88.7K
IEFA icon
7
iShares Core MSCI EAFE ETF
IEFA
$187B
$10.7M 3.17%
142,908
RGNX icon
8
Regenxbio
RGNX
$615M
$9.92M 2.94%
303,355
+6,000
+2% +$204K
TMO icon
9
Thermo Fisher Scientific
TMO
$214B
$9.8M 2.91%
14,680
-837
-5% -$523K
VTIP icon
10
Vanguard Short-Term Inflation-Protected Securities Index Fund
VTIP
$19.1B
$8.4M 2.49%
163,410
GRAB icon
11
Grab
GRAB
$14.1B
$7.54M 2.24%
+1,057,368
New +$8.07M
NAUT icon
12
Nautilus Biotechnolgy
NAUT
$152M
$7.51M 2.23%
+1,449,551
New +$7.76M
HOOD icon
13
Robinhood
HOOD
$83.3B
$7.22M 2.14%
+406,500
New +$12.5M
GPC icon
14
Genuine Parts
GPC
$17.9B
$6.76M 2.01%
47,940
ABCL icon
15
AbCellera Biologics
ABCL
$1.62B
$6.6M 1.96%
461,289
ATVI
16
DELISTED
Activision Blizzard
ATVI
$6.11M 1.81%
91,760
-979
-1% -$66.9K
RBLX icon
17
Roblox
RBLX
$35.4B
$5.94M 1.76%
57,615
+1,150
+2% +$112K
AMLP icon
18
Alerian MLP ETF
AMLP
$12.9B
$5.79M 1.72%
176,895
GBT
19
DELISTED
Global Blood Therapeutics, Inc.
GBT
$5.67M 1.68%
193,789
-3,000
-2% -$92.9K
CW icon
20
Curtiss-Wright
CW
$26.9B
$5.58M 1.66%
40,250
CFLT
21
DELISTED
Confluent
CFLT
$4.97M 1.47%
+65,184
New +$4.7M
EPD icon
22
Enterprise Products Partners
EPD
$83.6B
$3.62M 1.07%
164,856
-38,000
-19% -$852K
DASH icon
23
DoorDash
DASH
$85.2B
$2.79M 0.83%
+18,771
New +$3.55M
MMP
24
DELISTED
Magellan Midstream Partners, L.P.
MMP
$2.59M 0.77%
55,765
-31,290
-36% -$1.48M
DIS icon
25
Walt Disney
DIS
$172B
$2.55M 0.76%
16,469
-2,470
-13% -$399K

Similar funds

ArchPoint Investors's Q4 2021 Portfolio in Review

As of Q4 2021, ArchPoint Investors held 135 positions worth $337M, up 0.97% from $334M the previous quarter. Its ten largest holdings account for 65% of the portfolio.

ArchPoint Investors's Q4 2021 filing shows 17 new, 7 increased, 22 reduced and 68 closed positions. Its largest new stake was Recursion Pharmaceuticals: 1,255,430 shares worth $21.5M. The largest sale was Alphabet (Google) Class A, an estimated $26.7M.

By sector, the portfolio is most concentrated in Communication Services at 29% of assets, down from 35% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • ArchPoint Investors's largest Q4 2021 buy was Recursion Pharmaceuticals: 1,255,430 shares worth $21.5M.
  • ArchPoint Investors added most to Alibaba in Q4 2021, an estimated $805K increase.
  • ArchPoint Investors's biggest Q4 2021 reduction was Alphabet (Google) Class A, cutting an estimated $26.7M.
  • ArchPoint Investors fully exited Meta Platforms (Facebook) in Q4 2021, selling an estimated $1.24M.
  • ArchPoint Investors's ten largest holdings make up 65% of its $337M portfolio in Q4 2021.
  • ArchPoint Investors opened 17 new positions and closed 68 in Q4 2021.
  • ArchPoint Investors's portfolio value rose 0.97% quarter-over-quarter to $337M.

Based on ArchPoint Investors's 13F filing for Q4 2021, filed 11 Feb 2022.